tirzepatide kidney disease GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection with (#mounjaro) New Cleveland Clinic research finds
Description
Olsen BR, Reginato AM, Wang W
Obesity is a chronic disease that can cause many complications in the body, contributing to serious comorbidities and broader health issues, says Domenica Rubino, MD, founder and director, Washington Center for Weight Management & Research, in a release
mTOR kinase is a central regulatory protein that integrates various signals for cell growth and metabolism
They are essential tools in managing cardiovascular, renal, and metabolic conditions
After the first 46 weeks, as you enter the weight-loss phase, many patients see their systolic pressure drop 1020 mmHg
1236 Alvarez, A
